Pacific Biosciences of California, Inc. (NASDAQ:PACB): Are Traders Shorting This Stock?

When investors engage in short selling or "shorting a stock", they actually borrow shares from an existing owner, sell the borrowed shares at market price, and take the cash. The difference between the expected and actual EPS was $-0.03/share, which represents an Earnings surprise of -13%. The company's market cap is $317.13 million. The Company has 52-week high of $9.50 and 52-week low of $3.20.

This stock is ahead of its 52-week low with +2.96%. According to these analysts, the Low Revenue Estimate for Pacific Biosciences of California, 22.96 Million and the High Revenue Estimate is 24.8 Million.

PACB closed Thursday's regular trading session down 1.20% at $3.30. (PACB) reported earning per shares for the quarter ending April 26 AMC, whereas, 7 number of analysts estimated the mean EPS at -0.24.

The consensus analysts recommendation at this point stands at 1.90 on Pacific Biosciences of California, Inc. Analysts reported that the Price Target for Pacific Biosciences of California, Inc. might touch $8 high while the Average Price Target and Low price Target is $6.77 and $5.1 respectively.

Some buy side analysts are also providing their Analysis on Pacific Biosciences of California, Inc., where 2 analysts have rated the stock as Strong buy, 3 analysts have given a Buy signal, 2 said it's a HOLD, 0 reported it as Underperform and 0 analysts rated the stock as Sell.

Wall Street analysts are predicting that Pacific Biosciences (NASDAQ:PACB) will report earnings per share of $-0.24 in their quarterly report. Similarly, the company's last 5 years high P/E ratio is 0 and low P/E is 0, whereas, the industry's and sector's high P/E for the past year is 75.83 and 45.37 respectively and low P/E ratio for the last 5 years is 21.44 for the industry and 23.78 for the Sector.

The Relative Volume of the company is 3.37 and Average Volume (3 months) is 990.4 million.

Market capitalization is just a fancy declare for a comprehensible concept: it is the market value of a company's outstanding shares. P/E (price to earnings) ratio is 0 and Forward P/E ratio of 0. Pacific Biosciences (NASDAQ:PACB) has trailing twelve month Return on Assets of -53.9%, which is key indicator of how profitable a company is relative to its total assets. The Return on Equity (ROE) value stands at -87.5%.

While looking at the Stock's Performance, Pacific Biosciences of California, Inc. now shows a Weekly Performance of -3.79%, where Monthly Performance is -20.1%, Quarterly performance is -29.64%, 6 Months performance is -52.65% and yearly performance percentage is -64.21%. ROI is a performance measure used to evaluate the efficiency of an investment or to compare the efficiency of a number of different investments. The stock now has Weekly Volatility of 6.17% and Monthly Volatility of 4.85%. Likewise, the negative performance for the quarter was recorded as -29.64% and for the year was -64.21%, while the YTD performance remained at -13.16%.



Otras noticias